In this joint webinar, experts from Illumina, Twist Bioscience, and Enpicom will explore an end-to-end workflow for accelerating scFv discovery, from sequencing to synthetic library design to AI-driven analysis.
Together, these technologies form a unified discovery workflow that accelerates timelines and improves downstream outcomes across antibody engineering programs.
In this webinar, you will learn about:
- Illumina’s first ever longer read kit, the MiSeq™ i100 kit (25M, 1000 cycles) brings high-quality sequencing of variable regions and full scFv constructs to its most accessible platform, addressing long-standing challenges in AIRR-seq workflows.
- Using long read sequencing for full length VH/VL characterization enables finer enrichment analysis, improved clustering, accurate germline pairing, and faster identification of promising clones. This richer clonal resolution supports more confident selection and rapid advancement of antibody discovery programs.
- Computational pipelines accelerate scFv analysis, from sequence curation and clustering to generative models that propose novel variants and integrate directly with sequencing outputs.